Michael Mortensen

Direttore operativo presso BONESUPPORT HOLDING AB

Patrimonio netto: 799 635 $ in data 30/04/2024

Consumer Services

Health Technology

Posizioni attive di Michael Mortensen

Società	Posizione	Inizio	Fine
BONESUPPORT HOLDING AB	Direttore operativo	01/12/2021	-
BONESUPPORT HOLDING AB	Direttore Tecnico/Scientifico/R&S	01/12/2021	-
Nanovi Radiotherapy A/S Nanovi Radiotherapy A/S Pharmaceuticals: MajorHealth Technology Nanovi Radiotherapy A/S provides radiotherapy related products for the treatment of cancer. Its product BioXmark is a liquid ready-to-insert fiducial marker, which once inserted into soft tissue forms a semi-solid gel. The firm's platform provides an opportunity to encapsulate chemotherapeutics within the gel. The company was founded by Thomas Lars Andresen and Morten Albrechtsen in 2012 and is headquartered in Kongens Lyngby, Denmark.	Corporate Officer/Principal	-	-

University of Copenhagen	Doctorate Degree
Technical University of Denmark	Graduate Degree
AVT Business School A/S	Masters Business Admin

Distribuzione geografica

Danimarca	5
Svezia	2

Posizioni

Settori

Consumer Services	4
Health Technology	3

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
BONESUPPORT HOLDING AB	Health Technology

Aziende private	1
Nanovi Radiotherapy A/S Nanovi Radiotherapy A/S Pharmaceuticals: MajorHealth Technology Nanovi Radiotherapy A/S provides radiotherapy related products for the treatment of cancer. Its product BioXmark is a liquid ready-to-insert fiducial marker, which once inserted into soft tissue forms a semi-solid gel. The firm's platform provides an opportunity to encapsulate chemotherapeutics within the gel. The company was founded by Thomas Lars Andresen and Morten Albrechtsen in 2012 and is headquartered in Kongens Lyngby, Denmark.	Health Technology

Aziende private

Health Technology